Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Paulo Louzada Júnior
Causes of Synthetic Disease-Modifying Drug Discontinuation in Rheumatoid Arthritis: Data From a Large Real-Life Cohort
PLoS ONE
Multidisciplinary
Síndrome Do Anticorpo Antifosfolípide: Estudo Comparativo Das Formas Primária E Secundária
Revista Brasileira de Reumatologia
Related publications
Comparative Risk of Diabetes Mellitus in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease-Modifying Drugs: A Cohort Study
ACR Open Rheumatology
High Incidence of Disease Recurrence After Discontinuation of Disease-Modifying Antirheumatic Drug Treatment in Patients With Psoriatic Arthritis in Remission
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Real-World Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany
Clinical Therapeutics
Pharmacology
Safety of Abatacept Compared With Other Biologic and Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: Data From an Observational Study
Arthritis Research & Therapy
Leflunomide in Disease Modifying Treatment of Rheumatoid Arthritis in Elderly Patients
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Determining a Low Disease Activity Threshold for Decision to Maintain Disease-Modifying Antirheumatic Drug Treatment Unchanged in Rheumatoid Arthritis Patients
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Combined Disease Modifying Treatment of Rheumatoid Arthritis With Methotrexate and Hydroxychloroquine
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Lipid Profiles in Rheumatoid Arthritis Patients Treated With Disease-Modifying Antirheumatic Drugs
Reumatologia
Rheumatology
Allergy
Immunology
Predictors of Stopping and Starting Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis
Arthritis Care and Research
Rheumatology
